Composition:
Description:
Pridevin M1 is a combination of Metformin and Glimepiride in a SMART tablet formulation designed to effectively manage type 2 diabetes mellitus. This prolonged-release combination provides continuous blood glucose control by combining the glucose-lowering effects of Metformin with the insulin-secreting stimulation of Glimepiride.
Indications:
Pridevin M1 is indicated for:
Mechanism of Action:
Dosage and Administration:
Contraindications:
Warnings and Precautions:
Side Effects:
Common side effects may include:
Serious side effects, although rare, may include:
Drug Interactions:
Storage:
Packaging:
Disclaimer:
This information is provided for educational purposes only. For personalized medical advice and treatment options, consult a healthcare professional.